enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Protein Sciences - Wikipedia

    en.wikipedia.org/wiki/Protein_Sciences

    Protein Sciences has developed a novel method for vaccine production, using a genetically modified baculovirus that is allowed to reproduce in insect cells. [2] [3] This method reduces the lead time for vaccine production to six to eight weeks, considerably shorter than the conventional, egg-based, method. [4]

  3. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Sanofi

    Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...

  4. Sterling-Winthrop Research Centre - Wikipedia

    en.wikipedia.org/wiki/Sterling-Winthrop_Research...

    Former research took place at the Winthrop Laboratories site near the current Fawdon Metro station, which became Sanofi, on Edgefield Avenue in Fawdon; this site made Panadol and Solpadeine. In 1978 the company wanted to open a research site at Dukes House in Hexham , on a site of 38 acres, north of the building. [ 1 ]

  5. Marion Merrell Dow - Wikipedia

    en.wikipedia.org/wiki/Marion_Merrell_Dow

    Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996.. The company specialized in bringing to market drugs that had been discovered but unmarketed by other companies including Cardizem which treats arrhythmias and high blood pressure, Carafate (an ulcer treatment), Gaviscon (an antacid), Seldane (a ...

  6. Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings ... - AOL

    www.aol.com/sanofi-raises-2024-profit-outlook...

    On Thursday, Sanofi SA (NASDAQ:SNY) reported a second-quarter business operating income of 2.8 billion euros ($3.03 billion), up 3.2% year-over-year and 8.3% in constant currency. The company ...

  7. Bioverativ - Wikipedia

    en.wikipedia.org/wiki/Bioverativ

    sanofi.com Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia . [ 3 ] Bioverativ competes with Baxalta (acquired by Shire Plc in 2016 [ 4 ] ), Pfizer and Novo Nordisk . [ 2 ]

  8. Sanofi, AstraZeneca win US approval for RSV therapy ... - AOL

    www.aol.com/news/sanofi-astrazeneca-win-us...

    The expanded capacity will help the drugmakers meet the demand for Beyfortus ahead of the RSV season. The therapy was in tight supply last year. The U.S. health regulator greenlit the injected ...

  9. Sanofi Pasteur - Wikipedia

    en.wikipedia.org/wiki/Sanofi_Pasteur

    2004: merger of Aventis with and into Sanofi. The new Sanofi-Aventis Group becomes the world's 3rd largest pharmaceutical company, behind Pfizer and GlaxoSmithKline. Aventis Pasteur, the vaccine division of the Sanofi-Aventis Group, changes its name to Sanofi Pasteur. 2008: Sanofi Pasteur acquires Acambis plc, a biotech company.